Skip to main content
. 2015 Feb 13;58(4):1717–1735. doi: 10.1021/jm501436m

Figure 4.

Figure 4

(A) Inhibition of WNT-driven luciferase reporter activity. (B) Reduced tumor growth with compound 74 in COLO205 human colon cancer xenografts after oral dosing (70 mg/kg bid). (C) Plasma and tumor total concentrations of 74 at 2 and 6 h after the last dose.